Melatonin Sleep Gummies: The Rules in France and Europe

Why melatonin is so tightly regulated

Melatonin is a hormone naturally produced by the body that helps regulate the sleep-wake cycle. Depending on the dose, it can be sold as a food supplement or classified as a medicine. That borderline status explains the strict rules around sleep gummies in Europe, a sharp contrast with the US market, where melatonin gummies are sold freely as dietary supplements at much higher doses.

There is no harmonized maximum dose in the EU: each country sets its own rules. Some allow melatonin in supplements up to a threshold, others reserve it for medicines. A brand selling in several countries must check the rules of each market.

The daily limit in France

In France, food supplements may provide less than 2 mg of melatonin per day. That is why so many French products show 1.9 mg per daily dose: it is the highest value that stays under the threshold. Above it, the product falls outside the food supplement category.

In its 2018 opinion, the French agency ANSES also pointed to the lack of safety data on long-term daily use and recommended occasional use. A responsible brand factors that into the dose, the recommended duration of use and the label statements.

Authorized EU health claims

Two claims are authorized in the EU for melatonin, each with its own conditions of use:

• Contributes to the reduction of time taken to fall asleep : 1 mg of melatonin taken close to bedtime
• Contributes to the alleviation of subjective feelings of jet lag : At least 0.5 mg taken close to bedtime on the first day of travel and on the following few days after arrival

The wording must be used as authorized. Promises like "guaranteed deep sleep", "no more insomnia" or "sleep 8 hours" are not allowed in the EU. A sleep gummy must never suggest that it treats a sleep disorder.

Groups to exclude and recommended warnings

ANSES recommends that the following groups avoid melatonin food supplements:

• pregnant and breastfeeding women;
• children and teenagers;
• people with inflammatory or autoimmune diseases;
• people whose activities require sustained alertness, for whom drowsiness is a safety risk.

It also recommends medical advice beforehand for people with epilepsy, asthma, mood, behavior or personality disorders, or anyone taking medication. These warnings belong on the label of a melatonin gummy sold in France.

Why the gummy format needs extra care

A gummy looks like candy. For a melatonin product, that is a major concern, since children are one of the groups to exclude. A few best practices:

• Clear adult positioning: visuals, colors and shapes that do not appeal to children.
• Prominent statements: keep out of reach of young children, do not exceed the daily dose, groups advised against use.
• Tight dose control per gummy: each gummy must be uniform and tested, because the gap between the target dose and the legal threshold is small.
• Suitable packaging: a resealable bottle or doypack, ideally with a child-resistant closure.

Formulating a compliant sleep gummy

Melatonin is dosed in milligrams, so it takes up almost no room in a gummy. The challenge lies elsewhere: perfectly uniform distribution in the batch so that every gummy carries the same dose. In-process checks and release testing are essential.

Melatonin is often combined with other evening ingredients: botanical extracts such as lemon balm, chamomile or passionflower, L-theanine or magnesium. Each ingredient must be allowed in the target country and each claim verified. Botanical claims are still on hold at EU level and call for careful wording. More on our melatonin page.

Stability also matters. The actual melatonin content must stay close to the declared value throughout shelf life: too low and the claim is no longer supported, too high and the product may exceed the legal threshold. Stability studies and routine testing keep that margin under control.

For brands that also sell in the US, the contrast is striking: higher doses are common there, and consumers may compare labels across markets. A European melatonin gummy should present its lower dose as a feature, not a weakness: a dose aligned with the authorized claim, designed for occasional use, made in France under strict rules.

Packaging deserves the same attention. A tamper-evident seal, a clear dosage panel and a pack size that matches occasional use all send the right signal to regulators, pharmacists and consumers.

Notification and selling across borders

In France, every food supplement must be notified to the DGCCRF, the consumer protection authority, before it goes on sale. For a melatonin gummy, the file must show that the daily dose stays below the national threshold and that the label carries the expected statements. A mistake on dose or claims can stall a launch.

If you also sell abroad, check the rules of each destination: a product compliant in France may be refused elsewhere, and vice versa. In the UK and some EU member states, melatonin is a prescription medicine. In the US, the rules are different again. Our export team helps you prepare each market, and we can adapt dose or labeling by country.

A manufacturer that secures your label

Irati Production makes pectin gummies in Saumur, France, with a regulatory team that checks the dose, claims and mandatory statements of every product. Launching a new sleep product, a range extension for an established brand or a SKU for a lab? We start from our standard white label formulas or a custom development. And if your supplier is maxed out: need capacity? We are here.